Clinical Trials Sponsored by Scarless Laboratories, Inc.

Total 337 results

Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Atenolol 100mg Tablets Under Fasting Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalency Study of Fenofibrate 160mg Tablets Under Fasting Conditions

Healthy

India
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Clarithromycin 250 mg/5 mL Powder for Oral Suspension Under Fasting Conditions

Healthy

India
Ranbaxy Laboratories Limited

Completed

Bioequivaelnce Study of Clarithromycin 250 mg/5 mL Powder for Oral Suspension Under Fed Conditions

Healthy

India
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Clorazepate Dipotassium 15mg Tablets Under Fasting Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Carvedilol 12.5mg Tablets Under Fed Conditions

Healthy
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Clarithromycin 500 mg Tablets Under Non-Fasting Conditions

Healthy

United States
Stanford University
Starkey Laboratories, Inc

Recruiting

Fall Risk Assessment and Speech Intelligibility Enhancement Using In-ear Device

Vertigo | Dizziness | Hearing Loss

United States
Tris Pharma, Inc.
Forest Laboratories

Completed

Safety and Efficacy Study of GRT6005 in Patients With Osteoarthritis (OA) Knee Pain

Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee

United States
Tris Pharma, Inc.
Forest Laboratories

Completed

A Clinical Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of Cebranopadol

Pharmacokinetic

United States
NuBiyota
Glycemic Index Laboratories, Inc

Completed

Safety and Efficacy of MET-3 in Obese Human Subjects

Obesity

Canada
Forest Laboratories
Ironwood Pharmaceuticals, Inc.

Completed

An Open-Label, Long-term Study to Assess the Immunogenicity of LINZESS® (Linaclotide) Administered Orally to Adult Participants With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation

Irritable Bowel Syndrome With Constipation | Chronic Idiopathic Constipation

United States
Forest Laboratories
Ironwood Pharmaceuticals, Inc.

Completed

Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain

Opioid-Induced Constipation

United States
Ironwood Pharmaceuticals, Inc.
Forest Laboratories

Completed

Trial of Linaclotide in Patients With Chronic Idiopathic Constipation

Chronic Idiopathic Constipation

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Felodipine ER Tablets 10 mg Under Fasting Conditions

Healthy
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Fenofibrate Capsules, 130 mg Under Fed Conditions

Healthy
Orlando Health, Inc.
Forest Laboratories

Withdrawn

Ceftaroline in the Treatment of Bone and Joint Infections

Osteomyelitis | Joint Infections

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Valsartan 320mg Tablets Under Fed Conditions

Healthy

India
Ironwood Pharmaceuticals, Inc.
Forest Laboratories

Completed

Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

Irritable Bowel Syndrome With Constipation

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Pantoprazole Sodium 40 mg Delayed Release Tablets Fed Study

Healthy

India
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Ondansetron Orally Disintegrating Tablets 8mg Under Fasting Conditions

Healthy

India
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Ondansetron Orally Disintegrating Tablets 8mg Under Fed Conditions

Healthy

India
Ranbaxy Laboratories Limited

Completed

A Relative Bioavailability Study of Valacyclovir Hydrochloride Tablets 1gm Under Fed Condition

Healthy

India
Ranbaxy Laboratories Limited

Completed

A Relative Bioavailability Study of Acetaminophen 650 mg Extended Release Gelcaps Under Fasting Condition

Healthy

India
Forest Laboratories
Cypress Bioscience, Inc.

Completed

Study of Milnacipran for the Treatment of Fibromyalgia

Fibromyalgia

United States
Forest Laboratories
Cypress Bioscience, Inc.

Completed

A Study Of Milnacipran In Patients With Fibromyalgia: Effects On 24 Hour Ambulatory Blood Pressure Monitoring

Fibromyalgia

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Oxcarbazepine Oral Suspension 300 mg/5mL Under Fed Condition

Healthy

India
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Topiramate Tablets 25mg Under Fasting Conditions

Healthy

Canada
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Loratadine / Pseudoephedrine Sulfate 10/ 240 mg Extended-Release Tablets Under Fed Conditions

Healthy

Canada
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Zidovudine 300 mg Tablets, USP Under Fed Conditions

Healthy

Canada
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Zolpidem 10mg Tablets Under Fasting Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Metformin Hydrochloride 1000mg Tablets Under Fasting Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Loperamide Hydrochloride 2 mg and Simethicone 125 mg Tablet Under Fasting Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Metformin HCl 750 mg XR Under Fasting Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Gabapentin 400 mg Capsules Under Fasting Conditions

Healthy

Canada
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Amoxicillin-Clavulanic Acid 600 mg - 42.9 mg/ 5 mL Oral Suspension Under Fasting Conditions

Healthy

Canada
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Nitrofurantoin 100 mg Capsules Under Fed Conditions

Healthy

India
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Amoxicillin Dispersible 600 mg Tablets Under Fasting Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Fosinopril Sodium/ Hydrochlorothiazide 20/ 12.5 mg Tablets Under Fasting Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Gabapentin 400 mg Capsules Under Fed Conditions

Healthy

Canada
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Gabapentin 800 mg Tablets Under Fed Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Metformin Hydrochloride 1000mg Tablets Under Fed Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Metformin HCl 750 mg XR Tablets Under Non Fasting Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Loratadine Orally Disintegrating Tablets 10 mg Under Fed Conditions

Healthy
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Fosinopril 40mg Tablets Under Fasting Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Glimepiride 1mg Tablets Under Fasting Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Minocycline 100mg Tablets Under Fasting Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Amlodipine Tablets Under Fasting Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Carvedilol 12.5mg Tablets Under Fasting Conditions

Healthy
MGP Ingredients, Inc.
Glycemic Index Laboratories, Inc

Completed

Comparison of the Postprandial Glycemic and Insulinemic Response After a Fibersym Containing Cookie With a Control

Postprandial Hyperglycemia

Canada

3

Subscribe